Hypoxic Pulmonary Vasoconstriction Pilot Study

Completed · Phase 4

Conditions studied: Emphysema

In brief

The purpose of this study is to determine if the events leading to smoking-associated centrilobular and paraseptal emphysema are caused by a failure of the lungs' inherent mechanisms to block hypoxic pulmonary vasoconstriction (HPV) in areas of smoking-induced inflammation.

Key facts

Study ID
NCT03733470
Run by
Eric A. Hoffman
People needed
22
Starts
2011-06-29
Expected to finish
2014-01-13
Last updated by the study team
2019-10-01

Who can join

Age: 30 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.